Literature DB >> 31205150

Performance of 18F-FDG, 11C-Methionine, and 18F-FET PET for Glioma Grading: A Meta-analysis.

Aristeidis H Katsanos1,2, George A Alexiou2,3, Andreas D Fotopoulos4, Pascal Jabbour5, Athanasios P Kyritsis2,6, Chrissa Sioka2,5.   

Abstract

PURPOSE: Gliomas constitute the most frequent primary brain tumors. Glioblastoma, the most common and malignant glioma in adults, has dismal prognosis with any current therapy. On the other hand, low-grade gliomas, the second most common type of gliomas, are potentially curative with appropriate treatment.
METHODS: We conducted a meta-analysis to assess the performance of PET tracers with the best available evidence, namely, fluorodeoxyglucose (FDG), C-methionine (MET), and F-fluoroethyltyrosine (FET), in differentiating low- from high-grade gliomas.
RESULTS: Twenty-three studies with a total of 994 participants were included in this meta-analysis. The pooled sensitivities of both MET PET and FET PET were found to be significantly higher than of FDG PET (94%, 88%, and 63% respectively, P < 0.001). The pooled specificity of FDG PET was found to be significantly greater compared with both MET PET and FET PET (89%, 55%, and 57%, respectively; P = 0.002). Fluorodeoxyglucose PET was superior in terms of higher positive likelihood ratio values compared with both FET PET and MET PET.
CONCLUSIONS: This meta-analysis indicated that both MET and FET were superior to FDG in terms of sensitivity for identifying glioma grade.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31205150     DOI: 10.1097/RLU.0000000000002654

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  11 in total

1.  18F-Boramino acid PET/CT in healthy volunteers and glioma patients.

Authors:  Zhu Li; Ziren Kong; Junyi Chen; Jiyuan Li; Nan Li; Zhi Yang; Yu Wang; Zhibo Liu
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-02-15       Impact factor: 9.236

2.  Heme Biosynthesis Factors and 5-ALA Induced Fluorescence: Analysis of mRNA and Protein Expression in Fluorescing and Non-fluorescing Gliomas.

Authors:  Mario Mischkulnig; Thomas Roetzer-Pejrimovsky; Daniela Lötsch-Gojo; Nina Kastner; Katharina Bruckner; Romana Prihoda; Alexandra Lang; Mauricio Martinez-Moreno; Julia Furtner; Anna Berghoff; Adelheid Woehrer; Walter Berger; Georg Widhalm; Barbara Kiesel
Journal:  Front Med (Lausanne)       Date:  2022-05-18

3.  Dural Arteriovenous Fistula Mimicking a Brain Tumor on Methionine-positron Emission Tomography: A Case Report.

Authors:  Taketo Hanyu; Masahiro Nishihori; Takashi Izumi; Kazuya Motomura; Fumiharu Ohka; Shunsaku Goto; Yoshio Araki; Kinya Yokoyama; Kenji Uda; Ryuta Saito
Journal:  NMC Case Rep J       Date:  2022-09-15

Review 4.  Rapidly progressive dementias - aetiologies, diagnosis and management.

Authors:  Peter Hermann; Inga Zerr
Journal:  Nat Rev Neurol       Date:  2022-05-04       Impact factor: 44.711

Review 5.  Radiopharmaceuticals for PET and SPECT Imaging: A Literature Review over the Last Decade.

Authors:  George Crișan; Nastasia Sanda Moldovean-Cioroianu; Diana-Gabriela Timaru; Gabriel Andrieș; Călin Căinap; Vasile Chiș
Journal:  Int J Mol Sci       Date:  2022-04-30       Impact factor: 6.208

Review 6.  Insight into the Development of PET Radiopharmaceuticals for Oncology.

Authors:  Joseph Lau; Etienne Rousseau; Daniel Kwon; Kuo-Shyan Lin; François Bénard; Xiaoyuan Chen
Journal:  Cancers (Basel)       Date:  2020-05-21       Impact factor: 6.639

7.  Artificial Intelligence Algorithm-Based Positron Emission Tomography (PET) and Magnetic Resonance Imaging (MRI) in the Treatment of Glioma Biopsy.

Authors:  Wei Wei; Liujia Ma; Liying Yang; Rong Lu; Cong Xi
Journal:  Contrast Media Mol Imaging       Date:  2022-03-23       Impact factor: 3.161

8.  BRAF V600E mutation mediates FDG-methionine uptake mismatch in polymorphous low-grade neuroepithelial tumor of the young.

Authors:  Kensuke Tateishi; Naoki Ikegaya; Naoko Udaka; Jo Sasame; Takahiro Hayashi; Yohei Miyake; Tetsuhiko Okabe; Ryogo Minamimoto; Hidetoshi Murata; Daisuke Utsunomiya; Shoji Yamanaka; Tetsuya Yamamoto
Journal:  Acta Neuropathol Commun       Date:  2020-08-18       Impact factor: 7.801

Review 9.  Diagnostic Performance and Prognostic Value of PET/CT with Different Tracers for Brain Tumors: A Systematic Review of Published Meta-Analyses.

Authors:  Giorgio Treglia; Barbara Muoio; Gianluca Trevisi; Maria Vittoria Mattoli; Domenico Albano; Francesco Bertagna; Luca Giovanella
Journal:  Int J Mol Sci       Date:  2019-09-20       Impact factor: 5.923

10.  Feasibility on the Use of Radiomics Features of 11[C]-MET PET/CT in Central Nervous System Tumours: Preliminary Results on Potential Grading Discrimination Using a Machine Learning Model.

Authors:  Giorgio Russo; Alessandro Stefano; Pierpaolo Alongi; Albert Comelli; Barbara Catalfamo; Cristina Mantarro; Costanza Longo; Roberto Altieri; Francesco Certo; Sebastiano Cosentino; Maria Gabriella Sabini; Selene Richiusa; Giuseppe Maria Vincenzo Barbagallo; Massimo Ippolito
Journal:  Curr Oncol       Date:  2021-12-12       Impact factor: 3.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.